春立醫療(688236.SH):聘任盧宏悅擔任公司財務總監
格隆匯5月27日丨春立醫療(688236.SH)公佈,董事會於近日收到公司副總經理翟志永先生和財務總監李玉梅女士遞交的書面辭職申請,翟志永先生因個人原因申請辭去公司副總經理的職務,辭任後,翟志永先生將在公司繼續任職;李玉梅女士因個人原因申請辭去公司財務總監的職務,辭任後,李玉梅女士將在公司繼續任職。截至本公告披露日,翟志永先生持有公司股份4,960股,李玉梅女士未持有公司股份。
爲確保公司財務管理工作的順利開展,根據《公司法》等相關法律法規、規範性文件和《公司章程》的規定,經公司總經理提名,董事會提名委員會和董事會審計委員會審查通過,公司於2025年5月27日召開第五屆董事會第二十四次會議,審議通過了《關於高級管理人員辭任及聘任財務總監的議案》。同意聘任盧宏悅女士擔任公司財務總監,任期自本次董事會審議通過之日起至第五屆董事會任期屆滿之日止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.